Vitex Wins 2018 Quality Manufacturer of the Year Award

September 20, 2018

SYDNEY, Australia, 20 September 2018 – Vitex Pharmaceuticals has been awarded Quality Manufacturer of the Year at the 2018 Complementary Medicines Australia (CMA) Industry Awards. With other 400 guests in attendance, the annual event is held to recognise and celebrate the achievements of members across the Australian industry.

The High Quality Manufacturer of the Year Award honours and celebrates the company that has made the most significant contribution to the complementary medicines industry throughout the past year. The Award measures firms based on their commitment to and production of the highest standard products, and represents the complementary medicines industry to the highest standard.

“We are incredibly proud to have won the High Quality Manufacturer of the Year Award. This recognition by our industry colleagues is a testament to our ongoing commitment to quality and we are humbled to represent Australia in the global landscape as the benchmark for pharmaceutical manufacturing excellence,” said Dr Aniss Chami, Chief Executive Officer, Vitex.

“With increasing global demand for Australian made products, it is more apparent than ever to preserve our high quality manufacturing standards throughout the industry. This industry reputation has fuelled investment into Australia and contributes to the significant growth of employment and the local economy. We continue to take this responsibility seriously because we recognise the impact our business has on our community, clients and consumers,” concluded Dr Chami.

In November 2017, the Hon Malcolm Turnbull MP, Prime Minister of Australia, officially opened Vitex’s new best-in-class A$100 million manufacturing plant which will create close to 420 jobs in western Sydney.

-ENDS-

Read More

CEO of Vitex Pharmaceuticals, Dr Aniss Chami is proud to be appointed as a career ambassador for Careers NSW.
Read More >
Dr Aniss Chami, Chief Executive Officer of Vitex Pharmaceuticals interviewed by the Western Sydney Leadership Dialogue
Read More >
Vitex to Expand Into the Aerotropolis
Read More >
Vitex CEO Dr Aniss Chami Appointed Board Director of CHP Australia
Read More >
Vitex Pharmaceuticals’ Chief Executive Officer, Dr Aniss Chami, a panel discussion with Blacktown City Council.
Vitex CEO Dr Aniss Chami Joins A Panel Discussion with Blacktown City Council
Read More >
Vitex Pharmaceuticals’ Chief Procurement Officer, Lucie Chami, discusses the impact of Coronavirus on procurement via Podcast on Chartered Institute of Procurement and Supply
Vitex CPO Lucie Chami Discusses the Impact of Coronavirus
Read More >
Vitex Pharmaceuticals’ CEO, Dr Aniss Chami had the pleasure of hosting over forty foreign diplomats based in NSW. The Western Sydney Investment Attraction Office, on behalf of the Department of Foreign Affairs and Trade, organised a visit to Western Sydney to showcase investment and trade opportunities in this rapidly expanding region.
Vitex CEO Dr Aniss Chami Welcomes NSW Diplomats at Vitex Pharmaceuticals
Read More >
Vitex Pharmaceuticals Chief Executive Officer, Dr Aniss Chami, has been awarded the 2019 Corporate Citizen of the Year award by Blacktown City C
Vitex CEO Dr Aniss Chami Wins Corporate Citizen of the Year 2019 Award
Read More >
Vitex Pharmaceuticals’ CEO, Dr Aniss Chami joined the Western City & Aerotropolis Authority Industry Symposium that took place on Monday 16 December 2019 at Warwick Farm.
Vitex CEO Dr Aniss Chami Participates at the Western City & Aerotropolis Authority Industry Symposium
Read More >